VACCINE-CHALLENGED IMMUNE RESISTANCE TOWARD VIRUS A/CALIFORNIA/7/2009(H1N1)v IN IMMUNIZED PREGNANT WOMEN
https://doi.org/10.15789/1563-0625-2012-6-527-532
Abstract
Abstract. We studied immune resistance efficiency of vaccination against influenza A/California/7/2009(H1N1)v in women at second trimester of physiological pregnancy in a blind, placebocontrolled study. The first group included thirty pregnant women who were injected by univalent subunit “MonoGrippol plus” vaccine. The second group consisted of thirty-seven pregnant women immunized by trivalent “Grippol plus” vaccine. Thirty-one pregnant women (III group) received placebo treatment. Non-pregnant women (IV group) were injected with “MonoGrippol plus”. We did not find any differences in clinical features of vacccine-challenged time period in pregnant women from groups I-III. Notably, sufficient numbers of women were found to be seroprotected 1 month post-vaccination (I group, 80.0% ; II group, 75.7% ; IVgroup, 80.6% ) with high levels seroconversion (I group, 46.6%; II group, 51.4%; IV group, 53.3%). Within 9-10 months after vaccination, a decreased seroprotection was revealed in II group of pregnant women. More stable specific immunity levels were detected for the groups immunized with univalent vaccine.
Hence, the local subunit adjuvant “MonoGrippol plus” and “Grippol plus” vaccines were shown to exibit a high immune resistance efficiency profile and clinical safety, when used in pregnant women, thus presuming an extended application field for these biological drugs in public health service. State of pregnancy seems not to be a limiting condition for induction of specific immune resistance.About the Authors
A. Cherdantsev
ФГБОУ ВПО Ульяновский государственный университет, г. Ульяновск
Russian Federation
Russian Federation
M. Kostinov
НИИВС им. И.И. Мечникова, РАМН, Москва
Russian Federation
Russian Federation
А. Kuselman
ФГБОУ ВПО Ульяновский государственный университет, г. Ульяновск
Russian Federation
Russian Federation
Y. Dagil
НИИВС им. И.И. Мечникова, РАМН, Москва
Russian Federation
Russian Federation
A. A. Savis’ko
ФГБОУ ВПО Ростовский государственный медицинский университет, г. Ростов-на-Дону
Russian Federation
Russian Federation
References
1. Киселев О.И., Ершов Ф.И., Быков А.Т., Покровский В.И. Пандемия гриппа 2009/2010: противовирусная терапия и тактика лечения / НИИ гриппа СЗО РАМН. – СПб., 2010. – 97 с.
2. Противогриппозная вакцинация женщин во время беременности. Глобальный консультативный комитет по безопасности вакцин [Электронный ресурс]. – Режим доступа: http://www.who.int/vaccine_safety/topics/influenza/pregnancy/ru/index.html
3. Englund J.A. Maternal immunization with inactivated influenza vaccine: rationale and experience // Vaccine. – 2003. – Vol. 21. – P. 3460-3464.
4. Influenza vaccines, WHO Position Paper, Weekly Epidemiological Record. – 2005. – Vol. 80, N 33. – P. 277-288. – Режим доступа : http://www.who.int/entity/wer/2005/wer8033.pdf
5. Zaman K., M.B., B.S., Ph.D., Eliza Roy, M.B., B.S., D.C.H., Shams E. Arifeen, M.B., B.S., Dr.P.H., Mahbubur Rahman, M.B., B.S., Ph.D.,Rubhana Raqib, Ph.D., Emily Wilson, M.H.S., Saad B. Omer, M.B., B.S., Ph.D., Nigar S. Shahid, M.B., B.S., M.P.H., Robert F. Breiman, M.D., and Mark C. Steinhoff, M.D. / Effectiveness of Maternal Influenza Immunization in Mothers and Infants // New England J. of Medicine. – 2008. – Vol. 359. – P. 1555-1564.
6. Костинов М.П., Черданцев А.П., Сависько А.А., Тарбаева Д.А., Соловьева И.Л. Истинные и ложные реакции на введение вакцины против гриппа у беременных // Вопросы гинекологии, акушерства и перинатологии. – 2011. – Т. 10, № 6. – С. 38-42.
7. Черданцев А.П., Кусельман А.И., Синицына М.Н., Шалягина М.Е., Костинов М.П., Тарбаева Д.А. Изучение клинической безопасности вакцинации против гриппа у беременных // Медицинский альманах. – 2011. – № 4 (17). – C. 120-122.
8. Рекомендации по организации и проведению вакцинации беременных и родильниц против гриппа А (Н1N1) [Электронный ресурс]. – Режим доступа: http://www.minzdravsoc.ru/docs/mzsr/letters/161
9. Ботина А.В., Медведева Т.Г., Незнанов Н.Г. Этические аспекты проведения медицинских исследований на женщинах репродуктивного возраста // Качественная клиническая практика. – 2003. – № 3. – C. 43-46.
Review
For citations:
Cherdantsev A., Kostinov M., Kuselman А., Dagil Y., Savis’ko A.A. VACCINE-CHALLENGED IMMUNE RESISTANCE TOWARD VIRUS A/CALIFORNIA/7/2009(H1N1)v IN IMMUNIZED PREGNANT WOMEN. Medical Immunology (Russia). 2012;14(6):527-532. (In Russ.) https://doi.org/10.15789/1563-0625-2012-6-527-532
Views:
986
Email this article 